An Australian-led review of literature from 2017 to 2025 finds vaping likely causes DNA changes, tissue damage in the respiratory tract, and shifts in the oral microbiome that could raise cancer risk.

Evidence includes case reports of oral cancer in vapers and animal studies showing lung cancer and bladder changes after exposure to e-cigarette aerosols.

The comprehensive Australian assessment argues vaping is not a safe alternative to smoking and is likely to contribute to oral and lung cancer, challenging the idea that it’s safer or a cessation aid.

Regulatory implications discussed call for not treating vaping as a safe substitute, with emphasis on protecting youth and imposing stronger controls on access and marketing of vaping products.

Experts urge cautious interpretation of vaping safety and advocate proactive steps to reduce dual use and prevent cancer, especially among younger populations.

Many studies compare vaping to smoking rather than assessing vaping’s standalone risk, prompting calls to evaluate vaping independently.

Lead author says vaping is not an alternative to smoking or drugs and is dangerous, challenging the notion of safety or utility as a cessation aid.

Another key note from the lead author reinforces that vaping is hazardous in its own right and should not be considered a safe substitute.

The article foregrounds health concerns linked to vaping rather than promotional content, highlighting potential risks.

The risk assessment focuses on whether vaping causes pre-carcinogenic changes rather than exact incidence rates, due to limited long-term data.

UK actions such as bans on disposable vapes are noted, alongside concerns about lung cancer and COPD burdens and tobacco remaining a major risk factor.

The review argues precautionary labeling is insufficient and calls for stricter controls to minimize dual use and exposure, warning that vaping history may mirror tobacco’s cancer link.